These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone. Mazière B, Loc'h C, Baron JC, Sgouropoulos P, Duquesnoy N, D'Antona R, Cambon H. Eur J Pharmacol; 1985 Aug 27; 114(3):267-72. PubMed ID: 3877639 [Abstract] [Full Text] [Related]
4. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Bennett JP, Wooten GF. Ann Neurol; 1986 Apr 27; 19(4):378-83. PubMed ID: 3707090 [Abstract] [Full Text] [Related]
10. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions? Clements-Jewery S, Robson PA. Neuropharmacology; 1981 Dec 05; 20(12B):1295-8. PubMed ID: 7322304 [No Abstract] [Full Text] [Related]
11. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol. Morgan DG, Sinha YN, Finch CE. Neuroendocrinology; 1984 May 05; 38(5):407-10. PubMed ID: 6728123 [Abstract] [Full Text] [Related]
12. Specific in vivo binding of 77Br-brombenperidol in rat brain. Moerlein SM, Stöcklin G. Life Sci; 1984 Sep 24; 35(13):1357-63. PubMed ID: 6482657 [Abstract] [Full Text] [Related]
13. Effects of phospholipids on the specific binding of [3H]spiroperidol to the cholate extract of rat brain synaptic membranes. Moroi K, Hsu LL. Int J Biochem; 1985 Sep 24; 17(5):637-44. PubMed ID: 4029482 [Abstract] [Full Text] [Related]
14. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum. Cross AJ, Waddington JL. Eur J Pharmacol; 1981 May 08; 71(2-3):327-32. PubMed ID: 7250192 [Abstract] [Full Text] [Related]
15. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites. Coupet J, Rauh CE. Eur J Pharmacol; 1979 Apr 15; 55(2):215-8. PubMed ID: 456420 [Abstract] [Full Text] [Related]
16. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. Hall MD, Jenner P, Marsden CD. Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267 [Abstract] [Full Text] [Related]
17. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase. Bhargava HN. Life Sci; 1984 Feb 27; 34(9):873-9. PubMed ID: 6142397 [Abstract] [Full Text] [Related]
18. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication. Van der Werf JF, Van het Schip F, Sebens JB, Korf J. Eur J Pharmacol; 1984 Jul 20; 102(3-4):387-99. PubMed ID: 6436037 [Abstract] [Full Text] [Related]